Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Kull
K. Kull
Tartu University Hospital
Ulcerative colitis
Population
Medicine
Mesalazine
Rash
2
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.
2011
Alimentary Pharmacology & Therapeutics
Wolfgang Kruis
Laimas Jonaitis
Juris Pokrotnieks
Tatyana L. Mikhailova
Marek Horynski
Marian Bátovský
Y. S. Lozynsky
Y. Zakharash
István Rácz
K. Kull
Aleksandar Včev
M. Faszczyk
Karin Dilger
Roland Greinwald
Ralph Mueller
Show All
Source
Cite
Save
Citations (58)
P206 - Which patient population profits best from a high dose, once daily treatment with 3.0g mesalazine for maintaining clinical remission in ulcerative colitis? A subgroup analysis of a double-blind, double-dummy, randomised, controlled, dose-ranging study
2009
Journal of Crohns & Colitis
Wolfgang Kruis
Laimas Jonaitis
Limas Kupcinskas
Juris Pokrotnieks
G. Acute
Tatyana L. Mikhailova
Marek Horynski
M Batovsky
Y.S. Lozinskii
István Rácz
K. Kull
Aleksandar Včev
M. Faszczyk
Roland Greinwald
Ralph Mueller
Show All
Source
Cite
Save
Citations (0)
1